Literature DB >> 15630725

Correlates of depression, including overall and gastrointestinal functional status, among patients with systemic sclerosis.

Paul J Nietert1, Holly C Mitchell, Marcy B Bolster, Margaret Y Curran, Barbara C Tilley, Richard M Silver.   

Abstract

OBJECTIVE: Patients with systemic sclerosis (SSc) may develop psychological problems in addition to physiologic symptoms. We investigated whether demographic and clinical factors are associated with comorbid depression.
METHODS: From a university hospital's rheumatology clinic, 72 SSc patients who completed 3 questionnaires [Center for Epidemiologic Studies Depression (CES-D) scale, an abbreviated version of a functional status instrument, the Scleroderma Health Assessment Questionnaire (SHAQ), and the Gastrointestinal Quality of Life Index (GIQLI)] during an examination were recruited into the study. Correlations among scores on the 3 questionnaires [including upper and lower gastrointestinal (GI) tract subscales of the GIQLI] were calculated, and associations between CES-D scores and a variety of demographic and clinical characteristics were examined using stepwise linear regression.
RESULTS: Higher CES-D scores (i.e., more depression symptoms) were significantly correlated with upper (r = -0.48, p < 0.0001) and lower (r = -0.41, p < 0.001) GI tract dysfunction and worse overall functional status (r = 0.51, p < 0.0001). Stepwise regression indicated that higher levels of depression were independently associated with lower levels of education (p < 0.01), worse upper GI tract functioning (p = 0.019), worse functional status (p = 0.34), current corticosteroid use (p = 0.061), and cardiac involvement (p = 0.086).
CONCLUSION: Decreased functional status and abnormal GI functioning are significantly correlated with depression among patients with SSc. Other demographic and clinical indicators are also associated with depression.

Entities:  

Mesh:

Year:  2005        PMID: 15630725

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  21 in total

1.  Factors associated with oral hygiene practices among adults with systemic sclerosis.

Authors:  H K Yuen; F N Hant; C Hatfield; L M Summerlin; E A Smith; R M Silver
Journal:  Int J Dent Hyg       Date:  2013-10-15       Impact factor: 2.477

Review 2.  Prevalence and factors associated with glucocorticoids (GC) use in systemic sclerosis (SSc): a systematic review and meta-analysis of cohort studies and registries.

Authors:  Michele Iudici; Serena Fasano; Daniela Iacono; Barbara Russo; Giovanna Cuomo; Gabriele Valentini
Journal:  Clin Rheumatol       Date:  2013-11-19       Impact factor: 2.980

3.  Minimally important differences of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument.

Authors:  Dinesh Khanna; Daniel E Furst; Paul Maranian; James R Seibold; Ann Impens; Maureen D Mayes; Philip J Clements; Terri Getzug; Ron D Hays
Journal:  J Rheumatol       Date:  2011-07-01       Impact factor: 4.666

4.  Musculoskeletal Involvement in SSc Is Associated with Worse Scores on Short Form-36 and Scleroderma Health Assessment Questionnaire and Lower Tumor Necrosis Factor-α Gene Expression in Peripheral Blood Mononuclear Cells.

Authors:  Eliza R Pelrine; Marie-Dominique Ah-Kioon; Meng Zhang; Franck J Barrat; Robert F Spiera; Jessica K Gordon
Journal:  HSS J       Date:  2016-07-22

5.  Depression among the Moroccan systemic sclerosis.

Authors:  Fahd Wafki; Bouchra Amine; Yousra Ibn Yacoub; Assia Laatiriss; Fatima Znat; Redouane Abouqal; Najia Hajjaj-Hassouni
Journal:  Clin Rheumatol       Date:  2011-06-01       Impact factor: 2.980

Review 6.  Negative affect in systemic sclerosis.

Authors:  Leticia Leon; Lydia Abasolo; Marta Redondo; Miguel Angel Perez-Nieto; Luis Rodriguez-Rodriguez; Maria Isabel Casado; Rafael Curbelo; Juan Angel Jover
Journal:  Rheumatol Int       Date:  2013-09-27       Impact factor: 2.631

7.  Association of gastrointestinal involvement and depressive symptoms in patients with systemic sclerosis.

Authors:  Vijay Bodukam; Ron D Hays; Paul Maranian; Daniel E Furst; James R Seibold; Ann Impens; Maureen D Mayes; Philip J Clements; Dinesh Khanna
Journal:  Rheumatology (Oxford)       Date:  2010-09-30       Impact factor: 7.580

8.  Prevalence, Risk Factors and Assessment of Depressive Symptoms in Patients With Systemic Sclerosis.

Authors:  Christine March; Dörte Huscher; Emelina Preis; Alexander Makowka; Jakob Hoeppner; Frank Buttgereit; Gabriela Riemekasten; Kristina Norman; Elise Siegert
Journal:  Arch Rheumatol       Date:  2019-01-28       Impact factor: 1.472

9.  Reliability and validity of the University of California, Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument.

Authors:  Dinesh Khanna; Ron D Hays; Paul Maranian; James R Seibold; Ann Impens; Maureen D Mayes; Philip J Clements; Terri Getzug; Nihal Fathi; Amber Bechtel; Daniel E Furst
Journal:  Arthritis Rheum       Date:  2009-09-15

10.  Clinical Characteristics and Factors Associated With Disability and Impaired Quality of Life in Children With Juvenile Systemic Sclerosis: Results From the Childhood Arthritis and Rheumatology Research Alliance Legacy Registry.

Authors:  Brandi E Stevens; Kathryn S Torok; Suzanne C Li; Nicole Hershey; Megan Curran; Gloria C Higgins; Katharine F Moore; C Egla Rabinovich; Samuel Dodson; Anne M Stevens
Journal:  Arthritis Care Res (Hoboken)       Date:  2018-11-08       Impact factor: 4.794

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.